Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hemobiotech Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Hemobiotech Inc since year 2005.
Table 2 shows the detailed insider transactions of Hemobiotech Inc since 2005.
The reporting company's ticker symbol is HMBT. The reporting company's CIK number is 1301348.
The total value of stock buying since 2005 is $21,684.
The total value of stock sales since 2005 is $1,170,000.
The total value of stock option exercises since 2005 is $130,333.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2008-10-30||Bollon Arthur (Chief Executive Officer)||Option Ex||651,668||.20||130,333|
|2006-03-20||Baron Robert (Director)||Buy||3,150||1.75||5,512|
|2006-03-17||Baron Robert (Director)||Buy||1,850||1.85||3,422|
|2006-02-23||Baron Robert (Director)||Buy||5,000||1.95||9,750|
|2005-11-21||Rosenblum Mark J (Chief Financial Officer)||Buy||2,000||1.50||3,000|
Insider trading activities including stock purchases, stock sales, and option exercises of HMBT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hemobiotech Inc (symbol HMBT, CIK number 1301348) see the Securities and Exchange Commission (SEC) website.